Jonathan Woo Cunningham, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 32 | 2024 | 11701 | 2.780 |
Why?
|
Tetrazoles | 5 | 2024 | 909 | 2.020 |
Why?
|
Stroke Volume | 22 | 2024 | 5521 | 2.000 |
Why?
|
Natriuretic Peptide, Brain | 8 | 2024 | 1725 | 1.500 |
Why?
|
Ventricular Function, Left | 11 | 2024 | 3899 | 1.250 |
Why?
|
Diuretics | 4 | 2023 | 611 | 0.970 |
Why?
|
Biphenyl Compounds | 6 | 2024 | 1007 | 0.960 |
Why?
|
Drug Combinations | 4 | 2024 | 2048 | 0.900 |
Why?
|
Natriuretic Peptides | 3 | 2023 | 155 | 0.870 |
Why?
|
Peptide Fragments | 7 | 2024 | 5103 | 0.810 |
Why?
|
Heterocyclic Compounds, 2-Ring | 1 | 2020 | 38 | 0.720 |
Why?
|
Angiotensin Receptor Antagonists | 8 | 2024 | 1039 | 0.630 |
Why?
|
Sodium | 2 | 2022 | 1589 | 0.600 |
Why?
|
Troponin T | 2 | 2023 | 780 | 0.560 |
Why?
|
Troponin I | 1 | 2021 | 652 | 0.540 |
Why?
|
Spironolactone | 1 | 2020 | 412 | 0.530 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 15521 | 0.510 |
Why?
|
Amyloidosis | 1 | 2022 | 865 | 0.490 |
Why?
|
Benzimidazoles | 1 | 2020 | 858 | 0.480 |
Why?
|
Renal Insufficiency | 1 | 2019 | 808 | 0.440 |
Why?
|
Cardiomyopathies | 2 | 2023 | 2021 | 0.440 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1720 | 0.410 |
Why?
|
Proteomics | 2 | 2024 | 3840 | 0.380 |
Why?
|
Anti-Obesity Agents | 1 | 2014 | 227 | 0.370 |
Why?
|
Oxygen Consumption | 1 | 2017 | 1867 | 0.360 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2576 | 0.340 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2254 | 0.340 |
Why?
|
Benzhydryl Compounds | 3 | 2024 | 917 | 0.300 |
Why?
|
Heart Diseases | 1 | 2021 | 2795 | 0.300 |
Why?
|
Patient Selection | 1 | 2020 | 4246 | 0.290 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6506 | 0.260 |
Why?
|
Prognosis | 8 | 2024 | 29688 | 0.260 |
Why?
|
Length of Stay | 1 | 2019 | 6417 | 0.260 |
Why?
|
Electronic Health Records | 1 | 2023 | 4822 | 0.250 |
Why?
|
Humans | 45 | 2024 | 761222 | 0.240 |
Why?
|
Heart Defects, Congenital | 2 | 2022 | 4673 | 0.240 |
Why?
|
Pulmonary Artery | 1 | 2013 | 1929 | 0.240 |
Why?
|
Heart | 3 | 2023 | 4431 | 0.230 |
Why?
|
Heart Transplantation | 1 | 2017 | 3258 | 0.220 |
Why?
|
Aptamers, Nucleotide | 1 | 2024 | 164 | 0.210 |
Why?
|
Heart Failure, Diastolic | 1 | 2023 | 77 | 0.210 |
Why?
|
Furosemide | 1 | 2022 | 170 | 0.190 |
Why?
|
Hospitalization | 7 | 2023 | 10707 | 0.190 |
Why?
|
Double-Blind Method | 3 | 2020 | 12341 | 0.190 |
Why?
|
Neprilysin | 2 | 2024 | 478 | 0.190 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2023 | 197 | 0.190 |
Why?
|
Vasodilator Agents | 2 | 2023 | 989 | 0.190 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2022 | 2131 | 0.190 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 152 | 0.190 |
Why?
|
Glycine | 1 | 2024 | 659 | 0.180 |
Why?
|
Aged | 13 | 2024 | 169292 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11476 | 0.160 |
Why?
|
Embolism | 1 | 2022 | 399 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12159 | 0.160 |
Why?
|
Systole | 1 | 2020 | 936 | 0.150 |
Why?
|
Glucosides | 1 | 2022 | 512 | 0.150 |
Why?
|
Amyloid | 1 | 2022 | 848 | 0.140 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 431 | 0.140 |
Why?
|
Apolipoprotein E4 | 1 | 2021 | 709 | 0.140 |
Why?
|
Male | 17 | 2024 | 360703 | 0.140 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12676 | 0.140 |
Why?
|
Risk Factors | 7 | 2024 | 74241 | 0.130 |
Why?
|
Renin-Angiotensin System | 1 | 2021 | 735 | 0.130 |
Why?
|
Female | 18 | 2024 | 392552 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 832 | 0.130 |
Why?
|
Atherosclerosis | 2 | 2023 | 3407 | 0.130 |
Why?
|
Protein Precursors | 1 | 2020 | 1132 | 0.130 |
Why?
|
Hospital Mortality | 4 | 2021 | 5295 | 0.120 |
Why?
|
Hypoglycemia | 1 | 2022 | 883 | 0.120 |
Why?
|
Phentermine | 1 | 2014 | 31 | 0.120 |
Why?
|
Morbidity | 1 | 2020 | 1751 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8002 | 0.120 |
Why?
|
Survival Rate | 2 | 2020 | 12728 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2023 | 1163 | 0.110 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 941 | 0.110 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2013 | 28 | 0.110 |
Why?
|
Alagille Syndrome | 1 | 2013 | 45 | 0.110 |
Why?
|
Bupropion | 1 | 2014 | 304 | 0.100 |
Why?
|
Fructose | 1 | 2014 | 285 | 0.100 |
Why?
|
Middle Aged | 11 | 2024 | 220858 | 0.100 |
Why?
|
Benzazepines | 1 | 2014 | 310 | 0.100 |
Why?
|
Obesity | 1 | 2014 | 12940 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4111 | 0.100 |
Why?
|
Naltrexone | 1 | 2014 | 317 | 0.100 |
Why?
|
Organ Transplantation | 1 | 2021 | 1165 | 0.090 |
Why?
|
Williams Syndrome | 1 | 2013 | 194 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2022 | 1275 | 0.090 |
Why?
|
Angioplasty | 1 | 2013 | 356 | 0.090 |
Why?
|
Inpatients | 1 | 2022 | 2545 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10218 | 0.090 |
Why?
|
United States | 5 | 2023 | 72341 | 0.090 |
Why?
|
Constriction, Pathologic | 1 | 2013 | 1097 | 0.080 |
Why?
|
Exercise Test | 1 | 2017 | 2165 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2150 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5719 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7226 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2023 | 58952 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2021 | 3813 | 0.080 |
Why?
|
Critical Care | 1 | 2021 | 2696 | 0.080 |
Why?
|
Pyrimidines | 1 | 2020 | 3027 | 0.080 |
Why?
|
Prospective Studies | 5 | 2024 | 54437 | 0.070 |
Why?
|
Cause of Death | 1 | 2017 | 3688 | 0.070 |
Why?
|
Phenotype | 1 | 2022 | 16575 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15308 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2021 | 1504 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5114 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5842 | 0.060 |
Why?
|
Hypovolemia | 1 | 2023 | 48 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 151 | 0.050 |
Why?
|
Hemodynamics | 1 | 2013 | 4165 | 0.050 |
Why?
|
Time Factors | 2 | 2021 | 39957 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2020 | 64681 | 0.050 |
Why?
|
Cystatin C | 1 | 2023 | 270 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 274 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 459 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8663 | 0.040 |
Why?
|
Enalapril | 1 | 2022 | 310 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2021 | 8606 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9721 | 0.040 |
Why?
|
Risk Assessment | 1 | 2021 | 24022 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39127 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1128 | 0.040 |
Why?
|
Young Adult | 2 | 2023 | 59222 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 618 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 913 | 0.030 |
Why?
|
Adult | 3 | 2021 | 221120 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10516 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2021 | 1443 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2052 | 0.030 |
Why?
|
Death | 1 | 2020 | 677 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2021 | 915 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1598 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1517 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1241 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2021 | 1270 | 0.030 |
Why?
|
Warfarin | 1 | 2022 | 1482 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1212 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2022 | 1796 | 0.030 |
Why?
|
Patient Care Team | 1 | 2023 | 2515 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36170 | 0.020 |
Why?
|
Pyridines | 1 | 2022 | 2872 | 0.020 |
Why?
|
Child, Preschool | 1 | 2013 | 42225 | 0.020 |
Why?
|
Hemorrhage | 1 | 2022 | 3422 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2923 | 0.020 |
Why?
|
Myocardium | 1 | 2023 | 4746 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3441 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6304 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 80675 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7033 | 0.020 |
Why?
|
Genetic Variation | 1 | 2023 | 6567 | 0.020 |
Why?
|
Blood Glucose | 1 | 2022 | 6392 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8642 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3881 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8479 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 6988 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4795 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15841 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29893 | 0.010 |
Why?
|